Approvals/NMPA/Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ:IgG Fc Fusion Protein Injection

Approved

生物制品

Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ:IgG Fc Fusion Protein Injection

Approval Id: 1xoFk9dcJ2O
Approval Number: 国药准字S20233108
Generic Name: 重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白注射液
Generic Name En: Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ:IgG Fc Fusion Protein Injection
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 25mg（0.5ml）/支（预充式注射器）
Reg Date: 2023-03-28
Company Name: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Company Address: 中国（上海）自由贸易试验区李冰路399号
Production Company Name: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Production Company Address: 中国（上海）自由贸易试验区李冰路399号
Company Detail Path: /organization/sunshine-guojian-pharmaceutical-shanghai-co-ltd
Production Company Detail Path: /organization/sunshine-guojian-pharmaceutical-shanghai-co-ltd

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Mar 28, 2023

Approval ID

1xoFk9dcJ2O

Type

生物制品